Weaver Capital Management LLC Sells 280 Shares of Colgate-Palmolive Company (NYSE:CL)

Weaver Capital Management LLC trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 2.0% in the first quarter, Holdings Channel.com reports. The firm owned 13,507 shares of the company’s stock after selling 280 shares during the quarter. Weaver Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,266,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Cornerstone Wealth Management LLC increased its position in Colgate-Palmolive by 1.2% during the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock worth $847,000 after purchasing an additional 110 shares in the last quarter. Axxcess Wealth Management LLC increased its position in Colgate-Palmolive by 0.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock worth $3,526,000 after purchasing an additional 117 shares in the last quarter. Wescott Financial Advisory Group LLC increased its position in Colgate-Palmolive by 3.5% during the 4th quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company’s stock worth $320,000 after purchasing an additional 119 shares in the last quarter. Aberdeen Wealth Management LLC increased its position in Colgate-Palmolive by 0.6% during the 4th quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company’s stock worth $1,877,000 after purchasing an additional 125 shares in the last quarter. Finally, Town & Country Bank & Trust CO dba First Bankers Trust CO increased its position in Colgate-Palmolive by 4.0% during the 1st quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company’s stock worth $317,000 after purchasing an additional 130 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 0.4%

CL opened at $87.85 on Friday. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The company has a fifty day moving average of $91.50 and a 200-day moving average of $90.80. The stock has a market cap of $71.19 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 4.68 and a beta of 0.38.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the prior year, the company posted $0.86 earnings per share. Colgate-Palmolive’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive announced that its board has authorized a stock buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.76%.

Analysts Set New Price Targets

CL has been the subject of a number of research analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an “overweight” rating in a research report on Monday, April 28th. UBS Group upped their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a research report on Thursday, April 17th. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating for the company in a research report on Monday, March 31st. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. Finally, Barclays lowered their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating for the company in a research report on Friday, April 11th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.